A 70-year-old male has Aricept and Namenda; what would be an acceptable recommendation regarding this medication use?

Prepare for the American Board of Professional Psychology (ABPP) Exam with flashcards and multiple-choice questions. Each question includes insights and explanations to help you excel. Get ready for your certification journey!

Multiple Choice

A 70-year-old male has Aricept and Namenda; what would be an acceptable recommendation regarding this medication use?

Combining these two medications is acceptable because they work through different neurotransmitter systems, providing complementary effects rather than duplicating each other. Donepezil (Aricept) is a cholinesterase inhibitor that increases acetylcholine in the brain, which can help with cognitive symptoms. Memantine (Namenda) is an NMDA receptor antagonist that modulates glutamatergic activity, which can help in moderate to severe stages and may offer additional functional benefits. Using them together can yield additive benefit without overlapping mechanisms, which is why continuing the combination is appropriate. Adding another cholinesterase inhibitor would be duplicative and is not recommended. Stopping either medication could lessen potential benefits, so maintaining the combination is typically preferred in appropriate patients. Monitor for side effects from each drug (cholinergic effects like nausea or bradycardia from donepezil; dizziness or confusion from memantine) and adjust dosing if renal function affects memantine.

Combining these two medications is acceptable because they work through different neurotransmitter systems, providing complementary effects rather than duplicating each other. Donepezil (Aricept) is a cholinesterase inhibitor that increases acetylcholine in the brain, which can help with cognitive symptoms. Memantine (Namenda) is an NMDA receptor antagonist that modulates glutamatergic activity, which can help in moderate to severe stages and may offer additional functional benefits. Using them together can yield additive benefit without overlapping mechanisms, which is why continuing the combination is appropriate.

Adding another cholinesterase inhibitor would be duplicative and is not recommended. Stopping either medication could lessen potential benefits, so maintaining the combination is typically preferred in appropriate patients. Monitor for side effects from each drug (cholinergic effects like nausea or bradycardia from donepezil; dizziness or confusion from memantine) and adjust dosing if renal function affects memantine.

More practice questions